Molecular weight (DA)
60kD
Immunogen
The antiserum was produced against synthesized peptide derived from human ALS2CR13. AA range:411-460
Specificity
ALS2CR13 Polyclonal Antibody detects endogenous levels of ALS2CR13 protein.
Formulation
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Dilution rate
Western Blot: 1/500 - 1/2000. ELISA: 1/5000. Not yet tested in other applications.
Purification process (Immunogen)
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Background
miscellaneous:ALS2CR13 is mapped in the genomic region covering the complete candidate region for Amyotrophic lateral sclerosis 2 (ALS2).,sequence caution:Contaminating sequence. Sequence of unknown origin in the N-terminal part.,
Function
miscellaneous:ALS2CR13 is mapped in the genomic region covering the complete candidate region for Amyotrophic lateral sclerosis 2 (ALS2).,sequence caution:Contaminating sequence. Sequence of unknown origin in the N-terminal part.,
Protein name
Protein FAM117B
Other name
FAM117B; ALS2CR13; Protein FAM117B; Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein
Human protein sequence Database
Q6P1L5
Mouse protein sequence database
Q3U3E2
Rat protein sequence database
Cellular localization
cytoplasm,
Tissue expression
Human salivary gland,Kidney,Skin,